Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$304M |
| 2 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
+$189M |
| 3 |
AbbVie
ABBV
|
+$185M |
| 4 |
JPMorgan Ultra-Short Income ETF
JPST
|
+$176M |
| 5 |
iShares US Treasury Bond ETF
GOVT
|
+$174M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$430M |
| 2 |
Vanguard High Dividend Yield ETF
VYM
|
+$400M |
| 3 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$374M |
| 4 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$361M |
| 5 |
Invesco Actively Managed Exch-Traded Commodity Fd Tr Invesco Optimum Yield Diversified Commodity Strategy No K-1 ETF
PDBC
|
+$154M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.95% |
| 2 | Healthcare | 12.56% |
| 3 | Financials | 11.62% |
| 4 | Consumer Discretionary | 10.14% |
| 5 | Industrials | 9.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3051
InfuSystem Holdings
INFU
$185M
| $502K | ﹤0.01% |
52,171
+41,516
| +390% | +$376K |
|
3052
Ponce Financial Group
PDLB
$486M
| $502K | ﹤0.01% |
57,735
+46,752
| +426% | +$365K |
|
3053
MeiraGTx Holdings
MGTX
$1.11B
| $501K | ﹤0.01% |
74,544
+327
| +0.4% | +$2.1K |
|
3054
BCB Bancorp
BCBP
$177M
| $499K | ﹤0.01% |
42,505
+3,015
| +8% | +$34.4K |
|
3055
Village Super Market
VLGEA
$651M
| $499K | ﹤0.01% |
21,861
+190
| +0.9% | +$4.13K |
|
|
THRD
3056
DELISTED
Third Harmonic Bio
THRD
| $497K | ﹤0.01% |
103,270
+16,492
| +19% | +$78.5K |
|
3057
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
$66.3B
| $494K | ﹤0.01% |
6,254
-880
| -12% | -$69.9K |
|
3058
CorMedix
CRMD
$588M
| $494K | ﹤0.01% |
124,603
+101,999
| +451% | +$505K |
|
3059
Prudential
PUK
$38.5B
| $494K | ﹤0.01% |
17,431
+9,936
| +133% | +$284K |
|
3060
Orange County Bancorp
OBT
$506M
| $494K | ﹤0.01% |
+26,678
| New | +$471K |
|
|
QIPT
3061
DELISTED
Quipt Home Medical
QIPT
| $493K | ﹤0.01% |
+92,231
| New | +$544K |
|
|
TBCH
3062
Turtle Beach Corp
TBCH
$243M
| $492K | ﹤0.01% |
42,218
+1,478
| +4% | +$16.5K |
|
3063
Rigetti Computing
RGTI
$4.94B
| $492K | ﹤0.01% |
418,576
-139,849
| -25% | -$105K |
|
|
INZY
3064
DELISTED
Inozyme Pharma
INZY
| $492K | ﹤0.01% |
88,257
+71,708
| +433% | +$424K |
|
3065
FVCBankcorp
FVCB
$331M
| $491K | ﹤0.01% |
45,604
+6,913
| +18% | +$68.9K |
|
3066
CVRx
CVRX
$143M
| $491K | ﹤0.01% |
+31,793
| New | +$388K |
|
3067
Barclays
BCS
$93.4B
| $489K | ﹤0.01% |
62,222
+46,707
| +301% | +$361K |
|
|
CMBM
3068
DELISTED
Cambium Networks
CMBM
| $488K | ﹤0.01% |
32,036
-23,602
| -42% | -$366K |
|
3069
Celcuity
CELC
$4.27B
| $487K | ﹤0.01% |
+44,324
| New | +$461K |
|
3070
Acacia Research
ACTG
$426M
| $485K | ﹤0.01% |
116,573
+98,018
| +528% | +$396K |
|
3071
Parke Bancorp
PKBK
$396M
| $484K | ﹤0.01% |
28,509
+1,042
| +4% | +$17.5K |
|
|
PHLT
3072
DELISTED
Performant Healthcare Inc
PHLT
| $482K | ﹤0.01% |
178,689
+153,846
| +619% | +$445K |
|
3073
Oak Valley Bancorp
OVLY
$281M
| $481K | ﹤0.01% |
+19,102
| New | +$464K |
|
3074
Crawford & Co Class A
CRD.A
$532M
| $481K | ﹤0.01% |
43,338
-2,172
| -5% | -$20.9K |
|
3075
ARS Pharmaceuticals
SPRY
$559M
| $480K | ﹤0.01% |
71,611
+55,441
| +343% | +$370K |
|
Similar funds
Charles Schwab's Q2 2023 Portfolio in Review
As of Q2 2023, Charles Schwab held 3,760 positions worth $350B, up 6.4% from $329B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Charles Schwab's Q2 2023 filing shows 210 new, 2,215 increased, 1,001 reduced and 151 closed positions. Its largest new stake was iShares US Treasury Bond ETF: 7,510,883 shares worth $172M. The largest sale was Broadcom, an estimated $430M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 21% a quarter earlier, followed by Healthcare and Financials.
- Charles Schwab's largest Q2 2023 buy was iShares US Treasury Bond ETF: 7,510,883 shares worth $172M.
- Charles Schwab added most to State Street Technology Select Sector SPDR ETF in Q2 2023, an estimated $304M increase.
- Charles Schwab's biggest Q2 2023 reduction was Broadcom, cutting an estimated $430M.
- Charles Schwab fully exited iShares 0-1 Year Treasury Bond ETF in Q2 2023, selling an estimated $361M.
- Charles Schwab's ten largest holdings make up 19% of its $350B portfolio in Q2 2023.
- Charles Schwab opened 210 new positions and closed 151 in Q2 2023.
- Charles Schwab's portfolio value rose 6.4% quarter-over-quarter to $350B.
Based on Charles Schwab's 13F filing for Q2 2023, filed 10 Aug 2023.